Despite the growing body of research on the novel coronavirus, one question that may concern many people is whether they can get COVID-nineteen twice.

In this article, we have a look at the research to try to make up one's mind whether a person can get COVID-19 more than than once.

Stay informed with live updates on the current COVID-19 outbreak and visit our coronavirus hub for more communication on prevention and treatment.

a man getting tested for Coronavirus to see if he's had it twice Share on Pinterest
It is currently unknown whether a person develops long-term amnesty later on recovering from COVID-19.
Image credit: Alexander Hassenstein/Getty Images.

Anthony Fauci, Dr., the Director of the National Plant of Allergy and Infectious Diseases (NIAID) and Presidential Coronavirus Task Strength Advisor, believes that people who recover from COVID-xix should develop relatively robust immunity for at least a few months.

Dr. Fauci made this statement during an interview on April eighth, 2020, with JAMA editor Howard Bauchner.

Researchers and public health authorities all the same exercise non know how the human immune system responds to SARS-CoV-2 and whether or non people develop long-term immunity after recovering from COVID-19.

Fears about a possible lack of amnesty arose in response to contempo media reports of people testing positive for COVID-nineteen afterwards previously recovering from the illness.

It is difficult to say whether these individuals tested positive as a result of a second infection. While the possibility exists, it is more probable that detectable levels of the virus remain in the torso even after symptoms resolve.

The authors of a small study published in JAMA Network reported that 4 people tested positive 5–13 days afterwards showing clinical signs of recovery from mild to moderate COVID-19.

In a written report from the American Thoracic Society, researchers from Beijing nerveless pharynx swabs from 16 people with confirmed COVID-19.

One person had a false negative upshot, and half of the participants tested positive upward to 8 days later their symptoms resolved.

The innate immune organisation fights off strange pathogens, such equally viruses and bacteria. Specialized immune cells, called B-lymphocytes or B-cells, place proteins called antigens on the surface of invading cells.

When a B jail cell detects a new antigen, it causes the production of proteins, chosen antibodies, that bind to antigens.

Once an antibiotic locks onto an antigen, it attracts other cells that destroy the target.

When B cells produce a new antibody, they can keep making the same antibody if the same antigen appears in the future. This is called adaptive amnesty.

Theoretically, people who get COVID-xix should develop corresponding antibodies. Nonetheless, it is hard to say at this stage how these antibodies will reply to a future infection.

Immunity offers protection that extends beyond the individual level. When sufficient individuals have developed an constructive antibiotic response, additional benefits such as "herd immunity" go a possibility.

Herd amnesty occurs when a certain percentage of a population develops amnesty to an infectious disease.

Herd amnesty not simply protects those who are not immune, just it tin also slow downward and even end the spread of infectious diseases.

A population tin develop herd immunity in one of 3 ways:

  • The bulk of the population contracts the disease and generates a corresponding immune response.
  • Many people receive inactive or weak strains of the disease through vaccination.
  • A combination of both ways above occur.

Unfortunately, herd immunity will not end the spread of coronavirus at the moment, as researchers take withal to develop a vaccine.

Allowing the majority of the population to contract the virus could lead to hundreds of thousands of deaths.

Older individuals and those with chronic health conditions accept a higher risk of developing severe, life-threatening symptoms of COVID-19.

Herd immunity may not be a safe or feasible option at the moment. However, researchers are trying to understand how the allowed system reacts to SARS-CoV-ii.

Fortunately, it appears that about people who contract a SARS-CoV-2 infection quickly develop antibodies.

Researchers from Shanghai released a preliminary study, which has not even so been peer-reviewed, that evaluated the antibodies levels in blood samples from 175 people who recovered from balmy COVID-19 symptoms.

The bulk of participants adult antibodies within ten–fifteen days subsequently the onset of symptoms. Yet, ten participants had undetectable antibodies levels. The researchers also reported that elderly and eye-anile patients develop significantly college concentrations of antibodies than younger individuals.

The findings of this preliminary research suggest that people tin can develop varying degrees of immunity to SARS-CoV-2.

People must keep in mind that this preliminary study is non peer-reviewed. The researchers behind this report evaluated a small sample of individuals with mild COVID-19. Equally a result, their findings may not apply to the broader global population.

Research is ongoing into the possibility of reinfection with the novel coronavirus.

Researchers and public health authorities do non know how the immune system reacts to coronavirus or whether people who recover from COVID-19 develop long-term immunity.

In the meantime, experts propose that people continue to take preventative measures, such as concrete distancing and self-quarantining, if necessary.

For alive updates on the latest developments regarding the novel coronavirus and COVID-19, click here.